After approval and marketing of a pharmaceutical product, significant changes may be made in manufacturing the bulk drug substance.

This would be particularly true for the bulk drug substance manufacturer where reactors and centrifuges and piping between such large equipment can be sampled only using rinse solution samples.

This is particularly important for the foreign sterile bulk drug substance manufacturer where time is limited.